POLIOVIRUS VACCINE LIVE ORAL TRIVALENT HUMAN SOLUTION
Country: Canada
Language: English
Source: Health Canada
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-2; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-3
Available from:
AVENTIS PASTEUR LIMITED
ATC code:
J07BF02
INN (International Name):
POLIOMYELITIS ORAL, TRIVALENT, LIVE ATTENUATED
Dosage:
1000000UNIT; 100000UNIT; 150000UNIT
Pharmaceutical form:
SOLUTION
Composition:
POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1 1000000UNIT; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-2 100000UNIT; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-3 150000UNIT
Administration route:
ORAL
Units in package:
10X
Prescription type:
Schedule D
Therapeutic area:
VACCINES
Product summary:
Active ingredient group (AIG) number: 0319633001; AHFS:
Authorization status:
CANCELLED POST MARKET
Authorization date:
2005-07-21
